Genmab A/S (GEN.CO) Announces Results for the Nine Months Period of 2009
11/10/2009 11:01:21 AM
More...
|
Genmab A/S (GEN.CO) Announces Start of Ofatumumab Phase III Head to Head Study in DLBCL
11/9/2009 11:37:06 AM
More...
|
Danish Biotech Genmab A/S (GEN.CO) to Reorganize, to Sell U.S. Plant and Cut 300 Jobs
11/5/2009 8:46:48 AM
More...
|
GlaxoSmithKline (GSK), Genmab A/S (GEN.CO) Gets FDA Approval for Arzerra to Treat Leukemia; Approval Triggers $23 Million Payment to Genmab
10/27/2009 6:59:42 AM
More...
|
Genmab A/S (GEN.CO) Announces Positive Top-Line Results for Arzerra(tm) in Front Line NHL
8/26/2009 10:02:10 AM
More...
|
Genmab A/S (GEN.CO) Announces 2009 First Half Year Results
8/18/2009 11:10:09 AM
More...
|
Genmab A/S (GEN.CO), GlaxoSmithKline (GSK) (JOBS) Cancer Drug Arzerra Disappoints in Phase 3 Study
8/18/2009 6:42:18 AM
More...
|
GlaxoSmithKline (GSK) (JOBS), Genmab A/S (GEN.CO) Drug Meets Goal In Arthritis Study
7/30/2009 7:29:34 AM
More...
|
Genmab A/S (GNMSF.PK) Announces Lift of Zalutumumab Partial Clinical Hold
7/16/2009 9:30:23 AM
More...
|
FDA Delays GlaxoSmithKline (GSK), Genmab A/S (GNMSF.PK) Leukaemia Drug Ruling 3 Months
6/16/2009 7:20:16 AM
More...
|
|